Warren Buffett's big bet on kidney dialysis provider DaVita may finally be primed to start paying off, albeit after five frustrating years of negative returns.
Let's check out the charts.
GE will take months and months to build out a proper base that can support a sustained move.
Traders could go long on ISRG here, or wait to buy strength.
Are we late to the game with the stock up so much?
In order to get back into investor's good graces...FIT needs to demonstrate that it can get to annual profitability.
Small-caps have done better than their bigger brethren so far in 2019, and these three stocks are a reason why.
Vocera's applications extend beyond healthcare into long-term care facilities, nuclear facilities, hotels, and even retail.
One already is up nicely on its results, while the other two should issue reports of interest in the next few days.
The introduction of a new device, the Inspire, by the maker of fitness trackers comes after its shares already have surged 31% year to date.